An open labelled randomised comparative clinical and in vitro study to evaluate the effect of Pashanabhedadi kashaya ghana capsule and Pashanabheda kashaya ghana capsule in the management of Mootrashmari vis-Ã -vis Nephrolithiasis

An open labelled randomised comparative clinical and invitro study to evaluate the effect of Pashanabhedadi kashaya ghana capsule and Pashanabheda kashaya ghana capsule in the management of Mootrashmari vis-Ã -vis Nephrolithiasis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/053091

Enrollment

100

Registered

2023-05-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Mootrashmari vis-Ã -vis Nephrolithiasis as per the diagnostic criteria Patients with solitary or multiple renal calculi with size less than or equal to 10 mile meter size Participants are willing to provide informed consent

Exclusion criteria

Exclusion criteria: Patients with associated obstructive pathologies like BPH urethral stricture and congenital anatomical abnormalities Renal calculi in associated with uretreric bladder or uretral calculi During the phase of Renal colic and Ureteric colic Patients with severe Hydronephrosis Pregnant women and lactating mothers Systemic diseases which interfere with disease process and present clinical trial

Design outcomes

Primary

Measure	Time frame
EXPULTION OF KIDNEY STONESTimepoint: AT 45TH DAY	—

Secondary

Measure	Time frame
IMPROVEMENT OF QUALITY OF LIFE based on a questionnaireTimepoint: AT 45TH DAY	—

Countries

India

Contacts

Public ContactDr SHAILESH Y

SDMCA KUTHPADY UDUPI, KARNATAKA

shri9503@gmail.com9964899638

Outcome results